YY/T 0663.1-2021Cardiovascular implants - Endovascular devices - Part 1: Endovascular prostheses (English PDF)
心血管植入物 血管内器械 第1部分：血管内假体
Open the YY/T 0663.1-2021 preview as PDF
This is a limited preview
Buy now to download the full PDF (161 pages)
Issued by
NMPA
Level / Type
Industry · Recommended
Issue date
September 6, 2021
Implementation date
September 1, 2022
Scope
YY/T 0663.1-2021 is the English-translated version of 心血管植入物 血管内器械 第1部分：血管内假体.
YY/T 0663.1 is Part 1 of the Chinese endovascular device series, covering the endovascular prosthesis: the stent graft used to exclude an aortic aneurysm from the circulation without opening the chest or abdomen. It is the longest document in the series at 45,500 words, and the requirements reflect a device that has to be crimped into a delivery catheter, navigated through diseased vessels, deployed accurately at the first attempt and then hold for decades against pulsatile pressure and a changing aorta. Fabric integrity, fixation, migration resistance and endoleak behaviour are the properties the evaluation turns on. For a manufacturer or an importer of aortic stent grafts seeking Chinese registration, this is the governing standard.
Document preview — YY/T 0663.1-2021
National Standard of the People's Republic of China
- Classification
- C36
Issued by: National Medical Products Administration
Contents
- Foreword
- 1 Scope
- 2 Normative references
- 3 Terms and definitions
- About this edition
- Classification and status
- How a Chinese national standard is set out
- About this English translation
Foreword
This document was issued on 6 September 2021 by the National Medical Products Administration and takes effect on 1 September 2022.
It is a YY/T standard: it is recommended rather than compulsory, but it is the method a Chinese reviewer applies when assessing a registration submission.
It is classified under Chinese classification C36.
1 Scope
YY/T 0663.1 is Part 1 of the Chinese endovascular device series, covering the endovascular prosthesis: the stent graft used to exclude an aortic aneurysm from the circulation without opening the chest or abdomen. It is the longest document in the series at 45,500 words, and the requirements reflect a device that has to be crimped into a delivery catheter, navigated through diseased vessels, deployed accurately at the first attempt and then hold for decades against pulsatile pressure and a changing aorta. Fabric integrity, fixation, migration resistance and endoleak behaviour are the properties the evaluation turns on. For a manufacturer or an importer of aortic stent grafts seeking Chinese registration, this is the governing standard.
Remaining clauses in the full document
- 2 Normative references
- 3 Terms and definitions
- About this edition
- Classification and status
- How a Chinese national standard is set out
- About this English translation
......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 161 pages — is available in the English PDF.
Similar standards
YY/T 0079|YY/T 0979|YY 0091|YY/T 0663.2|YY 0336
How to Buy YY/T 0663.1-2021
- 1Add to cart. Click the "Buy YY/T 0663.1-2021" button on this page. You can add more standards before checkout.
- 2Checkout. Enter your email and billing details. Payment is processed securely by Stripe (cards, Apple Pay, Google Pay supported).
- 3Instant delivery (0–9 sec). Delivery is automatic: within seconds of payment you'll receive an email with a secure download link. The link stays valid for 72 hours.
- 4Invoice included. A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.
Related Standards
YY/T 0663.3-2016 — Cardiovascular implants - Endovascular devices - Part 3: Vena cava filters
YY/T 0297-2026 — General requirements for clinical investigation of medical devices
YY/T 0492-2026 — Implantable leads
Secure payment via Stripe
Payments accepted
YY/T 0663.1-2021
$1,355.00